Molecular Diagnostics

In Other News

• Amgen and Illumina Collaborate on Oncology Companion Diagnostic Test

• DNA-Enrichment Technology May Help Replace Biopsies for Cancer Mutation Testing

• Response of Early Stage Breast Cancer to Chemotherapy Predicted

• New System Breaks Technology and Cost Barriers for High-Throughput Large-Genome Sequencing

• Cancer Origin Test Covered by Large Private Health Insurer

• Genetic Mutation Appears to Drive Rare Brain Cancer

• Biomarker Improves Diagnosis of Esophageal Cancer

• Biopsy Test Predicts Aggressive form of Skin Cancer

• MicroRNAs Predict Likelihood of Breast Cancer Metastasis

• Blood Test Locates Gene Defects Linked to Cancer

• Horizon and AstraZeneca Announce Oncology Agreement

• Blood-Based Biomarkers Validated for Mild Cognitive Impairment

• Determination of Circulating CPN Cleavage Peptides Enables Early Diagnosis of Breast Cancer

• Molecular Diagnostics Optimized for Breast Cancer Tissue Samples

• Cervical Cancer Genomic Study Completed

• Causal Role Found for Common Genetic Variant in Narcolepsy

• Collaboration to Examine the Utility of KRAS Mutations in Urine

• Known Lung Cancer Oncogenes Drive Colorectal Cancer

• Myopathy Diagnosis Improved by New Gene Mutation

• Analysis of Saliva DNA Suggested for Screening Stroke-Linked Mutation

• Newly Identified Immune Receptor Activates B Cells in Autoimmunity

• Dominant Gene Mutations Causes Van der Woude Syndrome

• New Genetic Risk Factor for Type 2 Diabetes Uncovered